Stocks
Allogene Therapeutics (ALLO) P/S US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 52.6 | 3 705 | 5 303 | 14 449 | ||||
| Changes by years, y/y, % | +6 938% | +43% | +903.6% | ||||||
Allogene Therapeutics. P/S
Allogene Therapeutics. P/S, changes, %
Allogene Therapeutics (ALLO) P/S US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/S | ? | 2 857 | 3 377 | 5 815 | 5 148 | 13 622 | 14 449 | |
| Changes by years, y/y, % | -55% | -9% | +91% | +35% | +377% | |||
| Changes by quarters, q/q, % | -25% | +18% | +72% | -11% | +165% | |||
